12:00 AM
May 22, 2014
 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Addiction Metabotropic glutamate receptor subtype 2 (mGluR2; GRM2); mGluR3 (GRM3)...

Read the full 173 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >